STE
Steris Plc
NYSE · Health Care
$252.16
+8.35 (+3.42%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 5.41B | 5.10B | 18.40B | 19.50B | 17.35B |
| Net Income | 608.92M | 517.06M | 1.61B | 1.72B | 1.58B |
| EPS | — | — | — | — | — |
| Profit Margin | 11.3% | 10.7% | 8.8% | 8.8% | 9.1% |
| Rev Growth | +6.0% | +6.0% | +5.3% | -0.2% | +3.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 2.92B | 2.92B | 12.30B | 10.79B | 12.43B |
| Total Equity | 9.45B | 9.45B | 13.10B | 13.36B | 14.03B |
| D/E Ratio | 0.31 | 0.31 | 0.94 | 0.81 | 0.89 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 1.34B | 1.20B | 2.33B | 2.45B | 2.35B |
| Free Cash Flow | — | — | 1.70B | 1.74B | 1.69B |